GLA
Great Lakes Advisors Portfolio holdings
AUM
$11.9B
1-Year Return
22%
This Quarter Return
-11.85%
1 Year Return
+22%
3 Year Return
+78.34%
5 Year Return
+165.86%
10 Year Return
+347.64%
AUM
$5.06B
AUM Growth
-$1.04B
(-17%)
Cap. Flow
-$178M
Cap. Flow
% of AUM
-3.52%
Top 10 Holdings %
Top 10 Hldgs %
14.72%
Holding
771
New
72
Increased
195
Reduced
362
Closed
100
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$45.7M |
| 2 |
State Street
STT
|
$17.7M |
| 3 |
Equity Lifestyle Properties
ELS
|
$15.3M |
| 4 |
iShares Global REIT ETF
REET
|
$15.1M |
| 5 |
Pultegroup
PHM
|
$15.1M |
Top Sells
| 1 |
Oracle
ORCL
|
$24.7M |
| 2 |
Biogen
BIIB
|
$23.5M |
| 3 |
Wabtec
WAB
|
$23.5M |
| 4 |
AbbVie
ABBV
|
$19M |
| 5 |
Ameriprise Financial
AMP
|
$18.1M |
Sector Composition
| 1 | Technology | 14.39% |
| 2 | Healthcare | 14.17% |
| 3 | Financials | 13.07% |
| 4 | Industrials | 8.81% |
| 5 | Consumer Discretionary | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Amgen
AMGN
$151B
| $9.57M | 0.19% |
39,317
+19,461
| +98% | +$4.73M |
|
127
Colgate-Palmolive
CL
$67.6B
| $9.55M | 0.19% |
119,155
-14,996
| -11% | -$1.2M |
|
128
Axcelis
ACLS
$2.48B
| $9.52M | 0.19% |
173,590
-5,046
| -3% | -$277K |
|
129
iShares Russell 1000 Growth ETF
IWF
$118B
| $9.44M | 0.19% |
43,177
-12,461
| -22% | -$2.73M |
|
130
Elevance Health
ELV
$69.4B
| $9.41M | 0.19% |
19,506
+2,506
| +15% | +$1.21M |
|
131
Rambus
RMBS
$8.11B
| $9.4M | 0.19% |
437,591
-6,969
| -2% | -$150K |
|
132
Walmart
WMT
$805B
| $9.4M | 0.19% |
231,876
+27,369
| +13% | +$1.11M |
|
133
iShares MSCI EAFE Small-Cap ETF
SCZ
$10.7B
| $9.35M | 0.18% |
171,311
-89,219
| -34% | -$4.87M |
|
134
General Dynamics
GD
$86.7B
| $9.29M | 0.18% |
41,966
-7,191
| -15% | -$1.59M |
|
135
Corcept Therapeutics
CORT
$7.31B
| $9.14M | 0.18% |
384,231
-5,768
| -1% | -$137K |
|
136
Old National Bancorp
ONB
$9.08B
| $9.13M | 0.18% |
617,592
-12,079
| -2% | -$179K |
|
137
Sonoco
SON
$4.49B
| $9.12M | 0.18% |
159,908
-3,922
| -2% | -$224K |
|
138
Knowles
KN
$1.86B
| $8.95M | 0.18% |
516,320
+41,636
| +9% | +$722K |
|
139
Pacira BioSciences
PCRX
$1.2B
| $8.93M | 0.18% |
153,238
-6,078
| -4% | -$354K |
|
140
Lear
LEA
$5.87B
| $8.9M | 0.18% |
+70,656
| New | +$8.9M |
|
141
Technology Select Sector SPDR Fund
XLK
$84B
| $8.66M | 0.17% |
68,148
-436
| -0.6% | -$55.4K |
|
142
Cognizant
CTSH
$34.9B
| $8.65M | 0.17% |
128,090
-38,577
| -23% | -$2.6M |
|
143
LPL Financial
LPLA
$28.8B
| $8.64M | 0.17% |
+46,838
| New | +$8.64M |
|
144
Premier
PINC
$2.17B
| $8.57M | 0.17% |
240,066
-8,403
| -3% | -$300K |
|
145
Omega Healthcare
OHI
$12.6B
| $8.5M | 0.17% |
+301,424
| New | +$8.5M |
|
146
Ironwood Pharmaceuticals
IRWD
$179M
| $8.49M | 0.17% |
736,648
-11,039
| -1% | -$127K |
|
147
Owens & Minor
OMI
$417M
| $8.47M | 0.17% |
269,416
-6,918
| -3% | -$218K |
|
148
Lennar Class A
LEN
$35.8B
| $8.27M | 0.16% |
+121,041
| New | +$8.27M |
|
149
Phillips 66
PSX
$53.2B
| $8.16M | 0.16% |
99,562
-3,341
| -3% | -$274K |
|
150
Harmony Biosciences
HRMY
$2.09B
| $8.11M | 0.16% |
+166,338
| New | +$8.11M |
|